article thumbnail

Amber Specialty Pharmacy Named Partner of WeInfuse’s Specialty Pharmacy Connect Program

Amber

5, 2022) – Amber Specialty Pharmacy is excited to announce that it is a partner of WeInfuse’s Specialty Pharmacy Connect Program. Amber Specialty Pharmacy provides personalized and reliable care to those with complex and chronic conditions with a dedicated team that can guide patients through this new process.

article thumbnail

Fidelis Specialty Pharmacy Selects Citus Health to Enable Real-Time Virtual Patient Communications and Faster Collection of Key Patient Data

Citus Health Specialty Pharmacy

Innovative specialty pharmacy provider for hemophiliac and bleeding disorder patients to implement Citus Health’s HIPAA-compliant digital health solution suite to improve patient and staff communications, therapy adherence rates and patient outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Best Practices For A 340B Hospital Looking To Build An Onsite Specialty Pharmacy

Proxsys Rx

ProxsysRx recently gathered three of its corporate executives for an in-depth discussion of how an eligible health system can optimize revenues from its 340B program and its retail pharmacy, to help build and fund an onsite specialty pharmacy. For instance, is it helpful for a provider to know their specialty pharmacist?

article thumbnail

Navigating 340B Program Changes in 2025

Proxsys Rx

Engage in proactive communications with 340B program stakeholders Foster transparent relationships with drug manufacturers and wholesalers. Some have implemented exclusions for specialty pharmacies located outside arbitrarily-determined distances (typically 40 miles) from 340B entity campuses, significantly reducing savings opportunities.

article thumbnail

Best Practices For A 340B Hospital Looking To Build An Onsite Specialty Pharmacy

Proxsys Rx

ProxsysRx recently gathered three of its corporate executives for an in-depth discussion of how an eligible health system can optimize revenues from its 340B program and its retail pharmacy, to help build and fund an onsite specialty pharmacy. For instance, is it helpful for a provider to know their specialty pharmacist?

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. The time to cross that bridge has passed.

HIPAA 98
article thumbnail

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

Proxsys Rx

Establishing communication lines between internal and external 340B teams ProxsysRx’s 340B team leaders conduct twice-weekly calls with the team leaders of the health systems whose 340B programs they’re managing. Worse still, none of those silos are designed to enable easy communication with one another.